Search

Your search keyword '"Scarsella M"' showing total 222 results

Search Constraints

Start Over You searched for: Author "Scarsella M" Remove constraint Author: "Scarsella M"
222 results on '"Scarsella M"'

Search Results

1. Colloidal Structure of Heavy Crudes and Asphaltene Soltutions Structure colloïdale des bruts lourds et des suspensions d'asphaltènes

2. Mise en évidence de la polydispersité physico-chimique des asphaltènes Evidence of the Physicochemical Polydispersity of Asphaltenes

3. Exploiting Wideband Ultrasonic Signal Reception Trough Spiral-Shaped PVDF Sensors and Second Generation Voltage Conveyors

10. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

18. CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and

19. Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas

20. Evolution of Human Memory B Cells From Childhood to Old Age

24. The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory

27. Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma

31. MICROALGAE CULTURING IN THIN-LAYER PHOTOBIOREACTORS

32. Inhibition of poly(ADP-ribose) polymerase (PARP) increases the therapeutic efficacy of the G-quadruplex ligand RHPS4/irinotecan combination in colon cancer xenografts

33. Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors

34. Oral administration of poly(ADP-ribose) polymerase inhibitor prevents intestinal damage induced by irinotecan and enhances the efficacy of irinotecan and temozolomide combination against colon carcinoma

36. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint

37. Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I

38. Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice

39. Oral administration of the PARP inhibitor GPI 15427 increases the activity of anticancer drugs with different mechanisms of action

41. Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site

42. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents

Catalog

Books, media, physical & digital resources